New cancer clinical trial: Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

Published on: June 27, 2018 at 12:00PM
Conditions:   ATM Biallelic Inactivation;   ATM Gene Mutation;   ATM Monoallelic Inactivation;   BRCA1 Biallelic Inactivation;   BRCA1 Gene Mutation;   BRCA2 Biallelic Inactivation;   BRCA2 Gene Mutation;   FANCA Biallelic Inactivation;   Homologous Recombination Deficiency;   PALB2 Biallelic Inactivation;   PALB2 Gene Mutation;   Prostate Adenocarcinoma Without Evidence of Neuroendocrine Differentiation;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC v8
Interventions:   Drug: Olaparib;   Procedure: Radical Prostatectomy
Sponsors:   University of Washington;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2ICvuGN